BioFlow Dynamics is a Boston-based biotechnology company that has established itself as a notable player in the biotech ecosystem with $32 million in total funding through Series A. The company's name suggests a focus on biological flow systems or dynamics, potentially involving fluid mechanics applications in biotechnology, microfluidics, or bioprocessing technologies.
Operating from Boston, one of the world's leading biotechnology hubs, BioFlow Dynamics benefits from proximity to major research institutions, pharmaceutical companies, and a rich talent pool. The company's successful Series A funding round indicates strong investor confidence in its technology platform and market potential. The bioprocessing and microfluidics sectors have seen significant growth as pharmaceutical and biotech companies seek more efficient manufacturing and research tools, positioning BioFlow Dynamics in a market with substantial commercial opportunities.
| Date | Round | Amount | Lead Investor |
|---|---|---|---|
| Dec 2025 | Series A | $32M | Flagship Pioneering |
A Boston biotech company focused on biological flow systems and dynamics technologies, with $32M in Series A funding.
BioFlow Dynamics has raised $32M in total funding, with their most recent round being a Series A. The company operates in the Biotech sector.
BioFlow Dynamics operates in the Biotech sector. A Boston biotech company focused on biological flow systems and dynamics technologies, with $32M in Series A funding.
